Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of Celselect Slides 2.0 to enhance rare cell and circulating tumor cell (CTC) capture. Compatible with Bio-Rad’s Genesis Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback